A detailed history of Jpmorgan Chase & CO transactions in Organon & Co. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 633,330 shares of OGN stock, worth $9.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
633,330
Previous 684,957 7.54%
Holding current value
$9.85 Million
Previous $14.2 Million 14.55%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024

SELL
$18.65 - $23.03 $962,843 - $1.19 Million
-51,627 Reduced 7.54%
633,330 $12.1 Million
Q3 2024

Nov 08, 2024

SELL
$18.65 - $23.03 $962,843 - $1.19 Million
-51,627 Reduced 7.54%
633,330 $12.1 Million
Q2 2024

Dec 26, 2024

BUY
$17.45 - $21.96 $900,891 - $1.13 Million
51,627 Added 8.15%
684,957 $14.2 Million
Q2 2024

Aug 12, 2024

BUY
$17.45 - $21.96 $565,729 - $711,943
32,420 Added 4.97%
684,957 $14.2 Million
Q1 2024

Dec 26, 2024

BUY
$13.78 - $18.8 $264,672 - $361,091
19,207 Added 3.03%
652,537 $12.3 Million
Q1 2024

May 10, 2024

SELL
$13.78 - $18.8 $2.92 Million - $3.98 Million
-211,926 Reduced 24.52%
652,537 $12.3 Million
Q4 2023

Dec 26, 2024

BUY
$10.95 - $17.32 $2.53 Million - $4 Million
231,133 Added 36.49%
864,463 $12.5 Million
Q4 2023

Feb 12, 2024

SELL
$10.95 - $17.32 $4.07 Million - $6.44 Million
-371,635 Reduced 30.07%
864,463 $12.5 Million
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $2.48 Million - $3.56 Million
-149,728 Reduced 10.8%
1,236,098 $21.5 Million
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $13.4 Million - $17.1 Million
695,255 Added 100.68%
1,385,826 $28.8 Million
Q1 2023

May 18, 2023

BUY
$21.42 - $32.08 $5.38 Million - $8.06 Million
251,380 Added 57.24%
690,571 $16.2 Million
Q1 2023

May 11, 2023

SELL
$21.42 - $32.08 $12.1 Million - $18.1 Million
-562,676 Reduced 56.16%
439,191 $10.3 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $26.6 Million - $32.6 Million
-1,141,115 Reduced 53.25%
1,001,867 $28 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $3.01 Million - $4.4 Million
-128,556 Reduced 5.66%
2,142,982 $50.1 Million
Q2 2022

Aug 11, 2022

BUY
$31.66 - $38.9 $13.7 Million - $16.9 Million
434,292 Added 23.64%
2,271,538 $76.7 Million
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $45.6 Million - $59 Million
-1,498,812 Reduced 44.93%
1,837,246 $64.2 Million
Q4 2021

Feb 10, 2022

BUY
$28.67 - $37.13 $2.68 Million - $3.47 Million
93,481 Added 2.88%
3,336,058 $102 Million
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $92.8 Million - $116 Million
3,242,577 New
3,242,577 $106 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.